How to successfully map your research to the pharma landscape
Universities have long sought partnerships with the pharmaceutical industry to advance their research, but the license-to-the-highest bidder model has yielded high income for only a few institutions, and some have lost money in the pursuit of unfruitful patents and partnerships.
Understanding the research landscape within commercial organizations can help academic centers make smarter partnering decisions to advance healthcare and demonstrate an institution’s potential impact on patient lives.
In this webinar, our life sciences deal expert to dive deeper into partnering activity between academia and pharma, and provide insights on: